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· RESULTS:Sixty-fivepatientsmetinclusioncriteria. [1] [2] [3] [4] . Thoughmaculargridlasertreatmentisnotindicatedasa treatmentforMEduetoCRVOitwasfoundasbeneficialin casesofMEduetobranchretinalveinocclusionandatleast oncewasfoundaseffectiveinMEduetoCRVO [5] .Other medicalandsurgicaltherapiesthathavebeeninvestigatedas treatmentsforCRVOassociatedMEfailedtoachieveME absorptionorcausedundesirablesideeffects [6] [7] [8] [9] [10] [11] [12] [13] .Thus,the currentlyacceptedtreatmentforCRVOassociatedMEis anti-VEGFintravitrealinjections.Subsequentapplicationof maculargrid photocoagulationandpanretinal photocoagulation(PRP)wassuggestedwhensuchtreatment fails [14] .Severalstudies [3] [4] 13 [7] .Whilebothintravitreal bevacizumabinjectionsandmaculargridphotocoagulation+ PRP,havedemonstratedeffectiveness,someophthalmologists preferoneofthetreatmentsovertheother.Comparing outcomesofcombinedtreatmentin19patientswhosuffered 
